Publications and Presentations

Publications 

Presentations

2019

    • International Myeloma Workshop 2019, September, Boston, USA

- H. Blacklock et al., Pacific Islanders with multiple myeloma are younger and have inferior survival when compared to other ethnicities: a study from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
- P. Mollee et al., Receiving four or less cycles of therapy predicts poor survival in newly diagnosed transplant ineligible patients with myeloma who are treated with bortezomib-based induction
E. Moore et al., Patient-reported outcome measures in multiple myeloma: real-time reporting to improve care (My-PROMPT) - a pilot randomised controlled trial

2018

  • Inaugural Clinical Registries Summit, SPHPM, Monash, November 2018

A. Spencer. The Myeloma and Related Diseases Registry
N. Aoki, E. Moore. The APAC MRDR and other MRDR International Collaborations

  • Blood 2018, October, Brisbane

A. Spencer et al., MRDR Interest Group breakfast meeting
Z. McQuilten et al., Predictors of early mortality in multiple myeloma: Results from the ANZ MRDR
K. Bergin et al., The MRDR: the first five years - the myeloma landscape in ANZ (Nominated for HSANZ Outstanding Young Investigator Award)
E. Moore et al., Health-related quality of life at diagnosis in multiple myeloma: EQ-5D-5L results from the MRDR and comparison with an Australian population norm (Poster - Awarded Snowdome Foundation Haematology Nurse Myeloma Travel grant: $2500)

  • 2nd National Myeloma Workshop, Yarra Valley, Australia, September 2018

- E. Moore et al., Health-related quality of life at diagnosis in multiple myeloma: EQ-5D-5L results from the Myeloma and Related Diseases Registry (Poster)
- Z. McQuilten et al., Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (Poster)

2017

Talks including reference to or introduction of the MRDR:

  • H. Blacklock/T. King, National Haematology Nurses meeting, September 2017

2016

Talks including reference to or introduction of the MRDR:

  • S. Gibbs, Myeloma lectures, Royal Darwin Hospital, Aug 2016

2015

Talks including reference to or introduction of the MRDR:

  • A. Kalff, Binding site Educational Workshop, Melbourne, November, 2015
  • A. Kalff, Myeloma Australia, Medical scientific advisory group (MSAG) meeting, Melbourne, November, 2015
  • T. King, Update from IMW 2015 Rome: Nursing Symposium. HSANZ NG NSW Dinner Meeting. Sydney, November 2015 (poster)
  • T. King, Best practice in the administration of chemotherapy: Bortezomib focus. Tata Memorial Hspt Mumbai; Cancer Institute Chennai; Apollo Hospital Chennai; All India Institute of Medical Sciences (AIMS) Delhi; Rajiv Gandhi Cancer Institute Delhi India, August, 2015
  • A. Kalff, Myeloma Australia, medical scientific advisory group (MSAG) meeting, Melbourne, May, 2015

2014

  • A. Spencer, Myeloma Scientific Advisory Group, Myeloma Foundation Australia, Melbourne, Victoria
  • A. Spencer, MRDR Interest Group Meeting, HAA, Perth, Western Australia, October 2014

Talks including reference to or introduction of the MRDR:

  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Taipei, Taiwan, November 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Kaohsiung, Taiwan, November 2014
  • T. King, Making sense of myeloma: An overview of treatment. Leukaemia and Blood Cancer Foundation & HSANZ Nurses Group Educational meeting for nurses, September 2014 
  • T. King, Myeloma: An overview of disease, treatments and management of side effects. Leukaemia and Blood Cancer Foundation Patient and Family Forum Auckland New Zealand, September 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. The First Affiliated Hospital of College of Medicine Zhejiiang University. Hangzhou, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Shanghai Changzheng, Shanghaim, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Institute of Haematology and Blood Diseases Hospital Chinese Academy of Medical Sciences. Tianjin, China, February 2014

2013

  • A. Spencer HAA Investigator Meeting, Gold Coast, Queensland